Continued Validation of the RBD Symptom Severity Scale (RBDSSS) in Participants of the North American Prodromal Synucleinopathy (NAPS) Consortium (P6-13.004)
Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available